Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Richard F Pops. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Richard F Pops har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:NBIX / Neurocrine Biosciences, Inc. | Director | 34 480 |
US:ALKS / Alkermes plc | Director and CEO, Alkermes plc, Director | 1 290 390 |
US:EPZM / Epizyme Inc | Director | 14 013 |
US:XLRN / Acceleron Pharma Inc | Director | 7 500 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Richard F Pops. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ALKS / Alkermes plc - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ALKS / Alkermes plc. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ALKS / Alkermes plc. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Richard F Pops som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-22 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 2 869 | 34 480 | 9,08 | ||||
2025-02-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −79 925 | 1 290 390 | −5,83 | 31,39 | −2 508 846 | 40 505 342 | |
2025-02-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
A - Award | 190 640 | 1 370 315 | 16,16 | ||||
2024-05-21 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −2 100 | 31 611 | −6,23 | 141,84 | −297 860 | 4 483 651 |
2024-05-21 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 4 199 | 33 711 | 14,23 | ||||
2024-03-15 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −23 200 | 29 512 | −44,01 | 140,33 | −3 255 621 | 4 141 375 |
2024-03-15 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 23 200 | 52 712 | 78,61 | 42,76 | 992 032 | 2 253 965 | |
2024-03-12 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −100 | 29 512 | −0,34 | 140,00 | −14 000 | 4 131 680 |
2024-03-12 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 100 | 29 612 | 0,34 | 42,76 | 4 276 | 1 266 209 | |
2024-03-12 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −1 700 | 29 512 | −5,45 | 140,05 | −238 078 | 4 133 035 |
2024-03-12 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 1 700 | 31 212 | 5,76 | 42,76 | 72 692 | 1 334 625 | |
2024-02-22 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −15 000 | 29 512 | −33,70 | 132,47 | −1 987 047 | 3 909 449 |
2024-02-22 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 15 000 | 44 512 | 50,83 | 12,98 | 194 700 | 577 766 | |
2024-02-12 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −91 757 | 1 179 675 | −7,22 | 26,77 | −2 456 335 | 31 579 900 | |
2024-02-12 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
A - Award | 218 551 | 1 271 432 | 20,76 | ||||
2023-02-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −14 386 | 1 052 881 | −1,35 | 27,77 | −399 499 | 29 238 505 | |
2023-02-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 32 400 | 1 067 267 | 3,13 | ||||
2023-02-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −53 145 | 1 034 867 | −4,88 | 28,07 | −1 491 780 | 29 048 717 | |
2023-02-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
A - Award | 119 713 | 1 088 012 | 12,36 | ||||
2023-01-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −15 000 | 29 512 | −33,70 | 119,20 | −1 788 045 | 3 517 919 |
2023-01-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 15 000 | 44 512 | 50,83 | 12,71 | 190 650 | 565 748 | |
2022-05-20 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
A - Award | 9 724 | 9 724 | |||||
2022-05-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −7 500 | 0 | −100,00 | 6,66 | −49 950 | ||
2022-05-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −7 500 | 0 | −100,00 | 6,66 | −49 950 | ||
2022-05-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −7 500 | 29 512 | −20,26 | 76,30 | −572 252 | 2 251 772 |
2022-05-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 7 500 | 37 012 | 25,41 | 6,66 | 49 950 | 246 500 | |
2022-05-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 7 500 | 37 012 | 25,41 | 6,66 | 49 950 | 246 500 | |
2022-05-11 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −7 500 | 29 512 | −20,26 | 76,29 | −572 211 | 2 251 612 |
2022-05-06 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | −120 847 | 0 | −100,00 | ||||
2022-05-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | −93 747 | 968 299 | −8,83 | 27,85 | −2 611 313 | 26 971 872 | |
2022-05-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 120 847 | 1 062 046 | 12,84 | 16,55 | 2 000 018 | 17 576 861 | |
2022-05-06 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | −329 153 | 120 847 | −73,15 | ||||
2022-05-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | −32 288 | 941 199 | −3,32 | 28,59 | −923 227 | 26 912 174 | |
2022-05-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | −221 222 | 973 487 | −18,52 | 27,95 | −6 183 243 | 27 209 351 | |
2022-05-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 329 153 | 1 194 709 | 38,03 | 16,55 | 5 447 482 | 19 772 434 | |
2022-02-23 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −32 400 | 32 400 | −50,00 | ||||
2022-02-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −14 386 | 865 556 | −1,63 | 25,08 | −360 801 | 21 708 144 | |
2022-02-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 32 400 | 879 942 | 3,82 | ||||
2022-02-23 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 299 044 | 299 044 | |||||
2022-02-17 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −18 125 | 0 | −100,00 | ||||
2022-02-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −8 038 | 847 542 | −0,94 | 26,79 | −215 338 | 22 705 650 | |
2022-02-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 18 125 | 855 580 | 2,16 | ||||
2021-09-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −36 267 | 837 455 | −4,15 | 30,60 | −1 109 770 | 25 626 123 | |
2021-09-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
A - Award | 81 682 | 873 722 | 10,31 | ||||
2021-05-20 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
A - Award | 8 833 | 8 833 | |||||
2021-05-19 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −150 000 | 0 | −100,00 | |||
2021-05-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −150 000 | 792 040 | −15,92 | 21,90 | −3 285 405 | 17 347 815 |
2021-05-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 150 000 | 942 040 | 18,94 | 18,10 | 2 715 750 | 17 055 634 |
2021-05-12 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −150 000 | 150 000 | −50,00 | |||
2021-05-12 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −60 297 | 792 040 | −7,07 | 22,30 | −1 344 798 | 17 664 789 |
2021-05-12 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −89 703 | 852 337 | −9,52 | 21,95 | −1 968 541 | 18 704 621 |
2021-05-12 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 150 000 | 942 040 | 18,94 | 18,10 | 2 715 750 | 17 055 634 |
2021-05-07 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 300 000 | −25,00 | |||
2021-05-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −100 000 | 792 040 | −11,21 | 21,79 | −2 179 410 | 17 261 799 |
2021-05-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 100 000 | 892 040 | 12,63 | 18,10 | 1 810 500 | 16 150 384 |
2021-02-24 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 342 187 | 342 187 | |||||
2021-02-23 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −32 400 | 64 800 | −33,33 | ||||
2021-02-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −14 386 | 792 040 | −1,78 | 19,58 | −281 678 | 15 508 143 | |
2021-02-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 32 400 | 806 426 | 4,19 | ||||
2021-02-18 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 750 | 0 | −100,00 | ||||
2021-02-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 869 | 774 026 | −0,50 | 19,97 | −77 264 | 15 457 299 | |
2021-02-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 750 | 777 895 | 1,14 | ||||
2021-02-18 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −18 125 | 18 125 | −50,00 | ||||
2021-02-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −8 074 | 769 145 | −1,04 | 19,79 | −159 784 | 15 221 380 | |
2021-02-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 18 125 | 777 219 | 2,39 | ||||
2020-06-02 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | 14 013 | 14 013 | |||||
2020-05-21 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
A - Award | 6 018 | 6 018 | |||||
2020-05-14 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −75 000 | 0 | −100,00 | |||
2020-05-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −75 000 | 759 094 | −8,99 | 15,00 | −1 125 232 | 11 388 763 |
2020-05-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 75 000 | 834 094 | 9,88 | 11,74 | 880 500 | 9 792 264 |
2020-05-07 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 75 000 | −40,00 | |||
2020-05-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 759 094 | −6,18 | 14,63 | −731 265 | 11 101 977 |
2020-05-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 809 094 | 6,59 | 11,74 | 587 000 | 9 498 764 |
2020-04-03 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 125 000 | −28,57 | |||
2020-04-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 759 094 | −6,18 | 13,79 | −689 500 | 10 467 906 |
2020-04-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 809 094 | 6,59 | 11,74 | 587 000 | 9 498 764 |
2020-03-26 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −75 000 | 175 000 | −30,00 | |||
2020-03-26 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −75 000 | 759 094 | −8,99 | 14,36 | −1 077 225 | 10 902 867 |
2020-03-26 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 75 000 | 834 094 | 9,88 | 11,74 | 880 500 | 9 792 264 |
2020-03-19 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −75 000 | 250 000 | −23,08 | |||
2020-03-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −15 986 | 759 094 | −2,06 | 15,04 | −240 393 | 11 415 028 |
2020-03-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −48 668 | 775 080 | −5,91 | 14,51 | −706 168 | 11 246 333 |
2020-03-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −10 346 | 823 748 | −1,24 | 13,42 | −138 867 | 11 056 593 |
2020-03-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 75 000 | 834 094 | 9,88 | 11,74 | 880 500 | 9 792 264 |
2020-03-03 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −17 500 | 0 | −100,00 | ||||
2020-03-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −7 770 | 759 094 | −1,01 | 20,84 | −161 927 | 15 819 519 | |
2020-03-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 17 500 | 766 864 | 2,34 | ||||
2020-02-24 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −32 400 | 97 200 | −25,00 | ||||
2020-02-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −14 386 | 749 364 | −1,88 | 20,24 | −291 173 | 15 167 127 | |
2020-02-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 32 400 | 763 750 | 4,43 | ||||
2020-02-24 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 358 466 | 358 466 | |||||
2020-02-18 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 750 | 8 750 | −50,00 | ||||
2020-02-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 886 | 731 350 | −0,53 | 17,77 | −69 054 | 12 996 090 | |
2020-02-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 750 | 735 236 | 1,20 | ||||
2020-02-18 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −18 125 | 36 250 | −33,33 | ||||
2020-02-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −8 072 | 726 486 | −1,10 | 17,77 | −143 439 | 12 909 656 | |
2020-02-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 18 125 | 734 558 | 2,53 | ||||
2019-11-15 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 0 | −100,00 | |||
2019-11-15 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −100 000 | 716 433 | −12,25 | 19,50 | −1 950 000 | 13 970 444 |
2019-11-15 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 100 000 | 816 433 | 13,96 | 9,21 | 921 000 | 7 519 348 |
2019-11-08 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −30 205 | 100 000 | −23,20 | |||
2019-11-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −30 205 | 716 433 | −4,05 | 19,73 | −595 827 | 14 132 429 |
2019-11-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 30 205 | 746 638 | 4,22 | 9,21 | 278 188 | 6 876 536 |
2019-11-08 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −69 795 | 130 205 | −34,90 | |||
2019-11-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −69 795 | 716 433 | −8,88 | 19,81 | −1 382 618 | 14 192 323 |
2019-11-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 69 795 | 786 228 | 9,74 | 9,21 | 642 812 | 7 241 160 |
2019-09-23 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 200 000 | −33,33 | |||
2019-09-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −100 000 | 716 433 | −12,25 | 21,54 | −2 153 550 | 15 428 743 |
2019-09-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 100 000 | 816 433 | 13,96 | 9,21 | 921 000 | 7 519 348 |
2019-09-13 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 300 000 | −25,00 | |||
2019-09-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −100 000 | 716 433 | −12,25 | 22,68 | −2 268 220 | 16 250 277 |
2019-09-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 100 000 | 816 433 | 13,96 | 9,21 | 921 000 | 7 519 348 |
2019-09-06 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 400 000 | −20,00 | |||
2019-09-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −100 000 | 716 433 | −12,25 | 20,18 | −2 017 830 | 14 456 400 |
2019-09-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 100 000 | 816 433 | 13,96 | 9,21 | 921 000 | 7 519 348 |
2019-06-07 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | 17 633 | 17 633 | |||||
2019-05-24 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 0 | −100,00 | |||
2019-05-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 716 433 | −6,52 | 24,22 | −1 211 150 | 17 354 157 |
2019-05-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 766 433 | 6,98 | 8,55 | 427 500 | 6 553 002 |
2019-05-24 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −60 000 | 50 000 | −54,55 | |||
2019-05-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −60 000 | 716 433 | −7,73 | 25,42 | −1 525 278 | 18 212 658 |
2019-05-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 60 000 | 776 433 | 8,37 | 8,55 | 513 000 | 6 638 502 |
2019-05-23 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
A - Award | 10 000 | 10 000 | |||||
2019-03-14 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −15 829 | 110 000 | −12,58 | |||
2019-03-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −15 829 | 716 433 | −2,16 | 33,51 | −530 485 | 24 010 177 |
2019-03-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 15 829 | 732 262 | 2,21 | 8,55 | 135 338 | 6 260 840 |
2019-03-14 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −44 171 | 125 829 | −25,98 | |||
2019-03-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −44 171 | 716 433 | −5,81 | 33,24 | −1 468 447 | 23 817 529 |
2019-03-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 44 171 | 760 604 | 6,17 | 8,55 | 377 662 | 6 503 164 |
2019-03-07 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 170 000 | −22,73 | |||
2019-03-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 716 433 | −6,52 | 33,63 | −1 681 740 | 24 097 081 |
2019-03-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 766 433 | 6,98 | 8,55 | 427 500 | 6 553 002 |
2019-03-04 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −17 500 | 17 500 | −50,00 | ||||
2019-03-04 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −7 770 | 716 433 | −1,07 | 34,44 | −267 599 | 24 673 953 | |
2019-03-04 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 17 500 | 724 203 | 2,48 | ||||
2019-02-27 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2019-02-27 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 887 | 706 703 | −0,55 | 33,92 | −131 847 | 23 971 366 | |
2019-02-27 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 10 000 | 710 590 | 1,43 | ||||
2019-02-25 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 382 200 | 382 200 | |||||
2019-02-25 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 129 600 | 129 600 | |||||
2019-02-25 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 121 000 | 121 000 | |||||
2019-02-19 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 750 | 17 500 | −33,33 | ||||
2019-02-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −2 573 | 700 590 | −0,37 | 32,54 | −83 725 | 22 797 199 | |
2019-02-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 750 | 703 163 | 1,26 | ||||
2019-02-19 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −18 125 | 54 375 | −25,00 | ||||
2019-02-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −5 340 | 694 413 | −0,76 | 32,54 | −173 764 | 22 596 199 | |
2019-02-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 18 125 | 699 753 | 2,66 | ||||
2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 7 500 | 7 500 | |||||
2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 1 250 | 32 500 | 4,00 | ||||
2018-12-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −12 224 | 681 628 | −1,76 | 34,01 | −415 738 | 23 182 168 | |
2018-12-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
A - Award | 27 500 | 693 852 | 4,13 | ||||
2018-11-27 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −4 124 | 29 512 | −12,26 | 91,37 | −376 790 | 2 696 367 |
2018-11-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −4 123 | 33 636 | −10,92 | 103,30 | −425 893 | 3 474 491 |
2018-10-30 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −5 500 | 37 759 | −12,71 | 107,13 | −589 237 | 4 045 273 |
2018-05-31 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | 12 500 | 12 500 | |||||
2018-05-25 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
A - Award | 12 500 | 12 500 | |||||
2018-05-24 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2018-05-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −3 682 | 666 352 | −0,55 | 46,03 | −169 495 | 30 674 382 |
2018-05-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −16 318 | 670 034 | −2,38 | 45,33 | −739 669 | 30 371 569 |
2018-05-24 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 20 000 | 686 352 | 3,00 | 12,29 | 245 800 | 8 435 266 |
2018-05-17 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 20 000 | −71,43 | |||
2018-05-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 666 352 | −6,98 | 46,38 | −2 319 100 | 30 906 738 |
2018-05-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 716 352 | 7,50 | 12,29 | 614 500 | 8 803 966 |
2018-05-10 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 70 000 | −41,67 | |||
2018-05-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −7 360 | 666 352 | −1,09 | 44,55 | −327 863 | 29 683 716 |
2018-05-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −42 640 | 673 712 | −5,95 | 44,28 | −1 887 912 | 29 829 003 |
2018-05-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 716 352 | 7,50 | 12,29 | 614 500 | 8 803 966 |
2018-05-03 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 120 000 | −29,41 | |||
2018-05-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −900 | 666 352 | −0,13 | 44,66 | −40 197 | 29 761 479 |
2018-05-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −49 100 | 667 252 | −6,85 | 44,01 | −2 160 970 | 29 366 828 |
2018-05-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 716 352 | 7,50 | 12,29 | 614 500 | 8 803 966 |
2018-05-03 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | 15 000 | 0 | −100,00 | 7,05 | 105 750 | ||
2018-05-03 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
F - Taxes | −1 253 | 43 259 | −2,81 | 84,39 | −105 741 | 3 650 627 | |
2018-05-03 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 15 000 | 44 512 | 50,83 | 7,05 | 105 750 | 313 810 | |
2018-03-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −37 500 | 0 | −100,00 | ||||
2018-03-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | −2 902 | 31 250 | −8,50 | 42,32 | −122 813 | 1 322 500 | |
2018-03-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | −34 598 | 34 152 | −50,32 | 41,34 | −1 430 281 | 1 411 844 | |
2018-03-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 37 500 | 68 750 | 120,00 | 5,08 | 190 500 | 349 250 | |
2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 7 500 | 7 500 | |||||
2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 1 250 | 31 250 | 4,17 | ||||
2018-03-05 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −13 000 | 0 | −100,00 | ||||
2018-03-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −5 779 | 666 352 | −0,86 | 60,05 | −347 029 | 40 014 438 | |
2018-03-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 13 000 | 672 131 | 1,97 | ||||
2018-03-05 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −17 500 | 35 000 | −33,33 | ||||
2018-03-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −7 779 | 659 131 | −1,17 | 57,41 | −446 592 | 37 840 711 | |
2018-03-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 17 500 | 666 910 | 2,69 | ||||
2018-02-28 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −10 000 | 10 000 | −50,00 | ||||
2018-02-28 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −4 445 | 649 410 | −0,68 | 58,12 | −258 343 | 37 743 709 | |
2018-02-28 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 10 000 | 653 855 | 1,55 | ||||
2018-02-21 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 750 | 26 250 | −25,00 | ||||
2018-02-21 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −2 581 | 643 855 | −0,40 | 67,26 | −173 598 | 43 305 687 | |
2018-02-21 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 750 | 646 436 | 1,37 | ||||
2018-02-21 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 295 000 | 295 000 | |||||
2018-02-21 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 72 500 | 72 500 | |||||
2017-11-03 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 0 | −100,00 | |||
2017-11-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 637 686 | −7,27 | 48,87 | −2 443 410 | 31 162 567 |
2017-11-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 687 686 | 7,84 | 14,13 | 706 500 | 9 717 003 |
2017-06-26 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | 12 500 | 12 500 | |||||
2017-06-08 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 15 000 | 15 000 | |||||
2017-05-30 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −13 750 | 0 | −100,00 | ||||
2017-05-30 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −6 470 | 637 686 | −1,00 | 57,70 | −373 319 | 36 794 482 | |
2017-05-30 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 13 750 | 644 156 | 2,18 | ||||
2017-05-25 |
|
4 | ALKS |
Alkermes plc.
Incentive Stock Option (Right to Buy) |
M - Exercise | X | −6 269 | 0 | −100,00 | |||
2017-05-25 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −18 731 | 0 | −100,00 | |||
2017-05-25 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −25 000 | 630 406 | −3,81 | 57,42 | −1 435 535 | 36 198 795 |
2017-05-25 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 6 269 | 655 406 | 0,97 | 15,95 | 99 991 | 10 453 726 |
2017-05-25 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 18 731 | 649 137 | 2,97 | 15,95 | 298 759 | 10 353 735 |
2017-05-19 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 18 731 | −72,75 | |||
2017-05-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −5 939 | 630 406 | −0,93 | 59,06 | −350 743 | 37 230 265 |
2017-05-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −32 406 | 636 345 | −4,85 | 58,37 | −1 891 639 | 37 145 430 |
2017-05-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −11 655 | 668 751 | −1,71 | 57,23 | −667 058 | 38 275 027 |
2017-05-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 680 406 | 7,93 | 15,95 | 797 500 | 10 852 476 |
2017-05-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 68 731 | −26,67 | |||
2017-05-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −7 841 | 630 406 | −1,23 | 57,67 | −452 156 | 36 352 740 |
2017-05-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −17 159 | 638 247 | −2,62 | 57,12 | −980 088 | 36 455 392 |
2017-05-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 25 000 | 655 406 | 3,97 | 15,95 | 398 750 | 10 453 726 |
2017-05-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2017-05-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
F - Taxes | −952 | 29 512 | −3,12 | 53,37 | −50 808 | 1 575 055 | |
2017-05-05 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 15 000 | 30 454 | 97,06 | 3,40 | 51 000 | 103 544 | |
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 7 500 | 7 500 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 1 250 | 30 000 | 4,35 | ||||
2017-03-06 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −13 000 | 13 000 | −50,00 | ||||
2017-03-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −6 117 | 630 406 | −0,96 | 60,97 | −372 953 | 38 435 854 | |
2017-03-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 13 000 | 636 523 | 2,08 | ||||
2017-03-02 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −17 500 | 52 500 | −25,00 | ||||
2017-03-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −8 234 | 623 523 | −1,30 | 59,71 | −491 652 | 37 230 558 | |
2017-03-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 17 500 | 631 757 | 2,85 | ||||
2017-02-27 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −10 000 | 20 000 | −33,33 | ||||
2017-02-27 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −4 705 | 614 257 | −0,76 | 52,98 | −249 271 | 32 543 336 | |
2017-02-27 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 10 000 | 618 962 | 1,64 | ||||
2017-02-21 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 200 000 | 200 000 | |||||
2017-02-21 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 35 000 | 35 000 | |||||
2016-11-30 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −30 000 | 0 | −100,00 | |||
2016-11-30 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −2 050 | 608 962 | −0,34 | 57,72 | −118 320 | 35 147 642 |
2016-11-30 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −27 950 | 611 012 | −4,37 | 56,93 | −1 591 149 | 34 783 936 |
2016-11-30 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 30 000 | 638 962 | 4,93 | 14,38 | 431 400 | 9 188 274 |
2016-11-22 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −30 000 | 30 000 | −50,00 | |||
2016-11-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −6 885 | 608 962 | −1,12 | 59,44 | −409 218 | 36 194 326 |
2016-11-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −23 115 | 615 847 | −3,62 | 58,43 | −1 350 718 | 35 986 835 |
2016-11-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 30 000 | 638 962 | 4,93 | 14,38 | 431 400 | 9 188 274 |
2016-11-17 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −30 000 | 60 000 | −33,33 | |||
2016-11-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −2 060 | 608 962 | −0,34 | 59,29 | −122 133 | 36 104 200 |
2016-11-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −27 940 | 611 022 | −4,37 | 58,78 | −1 642 391 | 35 917 584 |
2016-11-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 30 000 | 638 962 | 4,93 | 14,38 | 431 400 | 9 188 274 |
2016-11-10 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −30 000 | 90 000 | −25,00 | |||
2016-11-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −8 946 | 608 962 | −1,45 | 53,82 | −481 466 | 32 773 787 |
2016-11-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −21 054 | 617 908 | −3,30 | 53,05 | −1 116 997 | 32 782 429 |
2016-11-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 30 000 | 638 962 | 4,93 | 14,38 | 431 400 | 9 188 274 |
2016-10-07 |
|
4 | ALKS |
Alkermes plc.
Performance Restricted Stock Units |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2016-10-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −9 410 | 608 962 | −1,52 | 46,43 | −436 906 | 28 274 106 | |
2016-10-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 20 000 | 618 372 | 3,34 | ||||
2016-06-01 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −13 750 | 13 750 | −50,00 | ||||
2016-06-01 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 13 750 | 598 372 | 2,35 | ||||
2016-05-26 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
S - Sale | X | −15 000 | 15 464 | −49,24 | 46,72 | −700 800 | 722 478 |
2016-05-24 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 15 000 | 15 000 | |||||
2016-05-24 |
|
4/A | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 25 000 | 25 000 | |||||
2016-05-23 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | 12 500 | 12 500 | |||||
2016-05-23 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 0 | −100,00 | ||||
2016-05-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 584 622 | 1,41 | ||||
2016-05-18 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2016-05-18 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
F - Taxes | −1 008 | 30 464 | −3,20 | 45,64 | −46 005 | 1 390 377 | |
2016-05-18 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 15 000 | 31 472 | 91,06 | 3,07 | 46 050 | 96 619 | |
2016-04-20 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −18 750 | 0 | −100,00 | |||
2016-04-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −18 750 | 576 497 | −3,15 | 40,15 | −752 863 | 23 147 911 |
2016-04-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 18 750 | 595 247 | 3,25 | 20,79 | 389 812 | 12 375 185 |
2016-04-13 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 18 750 | −57,14 | |||
2016-04-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −1 700 | 576 497 | −0,29 | 38,24 | −65 008 | 22 045 245 |
2016-04-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −23 300 | 578 197 | −3,87 | 37,76 | −879 831 | 21 833 297 |
2016-04-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 25 000 | 601 497 | 4,34 | 20,79 | 519 750 | 12 505 123 |
2016-03-23 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 43 750 | −36,36 | |||
2016-03-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −15 000 | 576 497 | −2,54 | 32,05 | −480 717 | 18 475 461 |
2016-03-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −10 000 | 591 497 | −1,66 | 31,36 | −313 636 | 18 551 475 |
2016-03-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 25 000 | 601 497 | 4,34 | 20,79 | 519 750 | 12 505 123 |
2016-03-16 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −20 190 | 68 750 | −22,70 | |||
2016-03-16 |
|
4 | ALKS |
Alkermes plc.
Incentive Stock Option (Right to Buy) |
M - Exercise | X | −4 810 | 0 | −100,00 | |||
2016-03-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −25 000 | 576 497 | −4,16 | 31,40 | −784 910 | 18 099 930 |
2016-03-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 20 190 | 601 497 | 3,47 | 20,79 | 419 750 | 12 505 123 |
2016-03-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 4 810 | 581 307 | 0,83 | 20,79 | 100 000 | 12 085 373 |
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
2016-03-04 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −13 000 | 26 000 | −33,33 | ||||
2016-03-04 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 13 000 | 576 497 | 2,31 | ||||
2016-03-01 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 70 000 | 70 000 | |||||
2016-03-01 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 300 000 | 300 000 | |||||
2016-03-01 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −10 000 | 30 000 | −25,00 | ||||
2016-03-01 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 10 000 | 563 497 | 1,81 | ||||
2015-12-08 |
|
4 | ALKS |
Alkermes plc.
Incentive Stock Option (Right to Buy) |
M - Exercise | X | −5 376 | 0 | −100,00 | |||
2015-12-08 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −32 124 | 0 | −100,00 | |||
2015-12-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −882 | 553 497 | −0,16 | 73,52 | −64 841 | 40 690 609 |
2015-12-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −9 210 | 554 379 | −1,63 | 72,51 | −667 799 | 40 196 913 |
2015-12-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −27 408 | 563 589 | −4,64 | 71,87 | −1 969 794 | 40 504 747 |
2015-12-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 5 376 | 590 997 | 0,92 | 18,60 | 99 994 | 10 992 544 |
2015-12-08 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 32 124 | 585 621 | 5,80 | 18,60 | 597 506 | 10 892 551 |
2015-12-02 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 32 124 | −60,88 | |||
2015-12-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −2 200 | 553 497 | −0,40 | 73,46 | −161 602 | 40 657 454 |
2015-12-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −24 052 | 555 697 | −4,15 | 72,48 | −1 743 171 | 40 274 196 |
2015-12-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −23 748 | 579 749 | −3,94 | 71,99 | −1 709 571 | 41 734 971 |
2015-12-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 603 497 | 9,03 | 18,60 | 930 000 | 11 225 044 |
2015-10-07 |
|
4 | ALKS |
Alkermes plc.
Performance Restricted Stock Units |
A - Award | 20 000 | 20 000 | |||||
2015-10-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −9 420 | 553 497 | −1,67 | 59,77 | −563 033 | 33 082 516 | |
2015-10-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
A - Award | 20 000 | 562 917 | 3,68 | ||||
2015-09-17 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 82 124 | −37,84 | |||
2015-09-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −27 579 | 542 917 | −4,83 | 71,58 | −1 974 072 | 38 861 347 |
2015-09-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −22 421 | 570 496 | −3,78 | 70,88 | −1 589 189 | 40 436 471 |
2015-09-17 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 592 917 | 9,21 | 18,60 | 930 000 | 11 028 256 |
2015-09-10 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 132 124 | −27,45 | |||
2015-09-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −20 009 | 542 917 | −3,55 | 68,12 | −1 363 013 | 36 983 506 |
2015-09-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −29 991 | 562 926 | −5,06 | 67,20 | −2 015 374 | 37 828 233 |
2015-09-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 592 917 | 9,21 | 18,60 | 930 000 | 11 028 256 |
2015-07-10 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | 7 333 | 7 333 | |||||
2015-06-01 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 25 000 | 25 000 | |||||
2015-05-29 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −13 750 | 27 500 | −33,33 | ||||
2015-05-29 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −6 477 | 542 917 | −1,18 | 59,92 | −388 102 | 32 531 587 | |
2015-05-29 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 13 750 | 549 394 | 2,57 | ||||
2015-05-22 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 8 125 | −50,00 | ||||
2015-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 827 | 535 644 | −0,71 | 61,80 | −236 509 | 33 102 799 | |
2015-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 539 471 | 1,53 | ||||
2015-05-22 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 0 | −100,00 | ||||
2015-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 827 | 531 346 | −0,72 | 62,10 | −237 657 | 32 996 587 | |
2015-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 535 173 | 1,54 | ||||
2015-05-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2015-05-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
F - Taxes | −1 801 | 16 472 | −9,86 | 39,63 | −71 374 | 652 785 | |
2015-05-13 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 15 000 | 18 273 | 458,30 | 4,76 | 71 400 | 86 979 | |
2015-04-08 |
|
4/A | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
2015-03-05 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −13 000 | 39 000 | −25,00 | ||||
2015-03-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −6 123 | 526 940 | −1,15 | 72,80 | −445 754 | 38 361 232 | |
2015-03-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 13 000 | 533 063 | 2,50 | ||||
2015-02-27 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 40 000 | 40 000 | |||||
2015-02-27 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 200 000 | 200 000 | |||||
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
2014-12-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 0 | −100,00 | |||
2014-12-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −4 621 | 520 063 | −0,88 | 56,76 | −262 292 | 29 519 192 |
2014-12-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −45 379 | 524 684 | −7,96 | 56,14 | −2 547 759 | 29 457 858 |
2014-12-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 14,90 | 745 000 | 8 493 939 |
2014-12-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 50 000 | −50,00 | |||
2014-12-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −1 500 | 520 063 | −0,29 | 56,56 | −84 837 | 29 413 567 |
2014-12-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −48 500 | 521 563 | −8,51 | 55,86 | −2 709 302 | 29 135 500 |
2014-12-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 14,90 | 745 000 | 8 493 939 |
2014-11-13 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 100 000 | −33,33 | |||
2014-11-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 520 063 | −8,77 | 52,88 | −2 643 990 | 27 500 827 |
2014-11-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 14,90 | 745 000 | 8 493 939 |
2014-11-13 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 150 000 | −25,00 | |||
2014-11-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 520 063 | −8,77 | 52,86 | −2 643 175 | 27 492 350 |
2014-11-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 14,90 | 745 000 | 8 493 939 |
2014-10-16 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 200 000 | −20,00 | |||
2014-10-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −31 800 | 520 063 | −5,76 | 41,34 | −1 314 488 | 21 497 376 |
2014-10-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −18 200 | 551 863 | −3,19 | 40,90 | −744 424 | 22 572 521 |
2014-10-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 14,90 | 745 000 | 8 493 939 |
2014-10-16 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 250 000 | −16,67 | |||
2014-10-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −12 700 | 520 063 | −2,38 | 41,50 | −527 096 | 21 584 487 |
2014-10-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −37 300 | 532 763 | −6,54 | 40,91 | −1 526 014 | 21 796 347 |
2014-10-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 14,90 | 745 000 | 8 493 939 |
2014-09-19 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 300 000 | −14,29 | |||
2014-09-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 520 063 | −8,77 | 44,89 | −2 244 585 | 23 346 512 |
2014-09-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 14,90 | 745 000 | 8 493 939 |
2014-07-25 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | 7 333 | 7 333 | |||||
2014-07-07 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 0 | −100,00 | |||
2014-07-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −1 400 | 520 063 | −0,27 | 52,07 | −72 904 | 27 082 073 |
2014-07-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −48 600 | 521 463 | −8,53 | 51,68 | −2 511 463 | 26 947 226 |
2014-07-07 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 12,30 | 615 000 | 7 011 775 |
2014-06-27 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 50 000 | −50,00 | |||
2014-06-27 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −200 | 520 063 | −0,04 | 50,70 | −10 140 | 26 367 194 |
2014-06-27 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −49 800 | 520 263 | −8,74 | 49,87 | −2 483 546 | 25 945 724 |
2014-06-27 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 570 063 | 9,61 | 12,30 | 615 000 | 7 011 775 |
2014-06-20 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −41 870 | 100 000 | −29,51 | |||
2014-06-20 |
|
4 | ALKS |
Alkermes plc.
Incentive Stock Option (Right to Buy) |
M - Exercise | X | −8 130 | 0 | −100,00 | |||
2014-06-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −1 300 | 520 063 | −0,25 | 47,51 | −61 765 | 24 709 025 |
2014-06-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −48 700 | 521 363 | −8,54 | 46,70 | −2 274 246 | 24 347 183 |
2014-06-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 41 870 | 570 063 | 7,93 | 12,30 | 515 001 | 7 011 775 |
2014-06-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 8 130 | 528 193 | 1,56 | 12,30 | 99 999 | 6 496 774 |
2014-05-30 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −13 750 | 41 250 | −25,00 | ||||
2014-05-30 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −6 484 | 520 063 | −1,23 | 45,74 | −296 578 | 23 787 682 | |
2014-05-30 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 13 750 | 526 547 | 2,68 | ||||
2014-05-22 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 15 000 | 15 000 | |||||
2014-05-22 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 16 250 | −33,33 | ||||
2014-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 831 | 512 797 | −0,74 | 44,48 | −170 403 | 22 809 211 | |
2014-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 516 628 | 1,60 | ||||
2014-05-22 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 8 125 | −50,00 | ||||
2014-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 831 | 508 503 | −0,75 | 43,98 | −168 487 | 22 363 962 | |
2014-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 512 334 | 1,61 | ||||
2014-05-20 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 0 | −100,00 | ||||
2014-05-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 831 | 504 209 | −0,75 | 43,59 | −166 993 | 21 978 470 | |
2014-05-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 508 040 | 1,63 | ||||
2014-05-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
M - Exercise | −12 000 | 0 | −100,00 | ||||
2014-05-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
F - Taxes | −10 258 | 3 273 | −75,81 | 14,47 | −148 433 | 47 360 | |
2014-05-14 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 12 000 | 13 531 | 783,80 | 12,37 | 148 440 | 167 378 | |
2014-03-05 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 52 000 | 52 000 | |||||
2014-03-05 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 230 000 | 230 000 | |||||
2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 20 000 | 20 000 | |||||
2013-11-19 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Award |
M - Exercise | −125 000 | 0 | −100,00 | ||||
2013-11-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −59 001 | 499 915 | −10,56 | 36,89 | −2 176 547 | 18 441 864 | |
2013-11-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 125 000 | 558 916 | 28,81 | ||||
2013-09-18 | 3 | XLRN |
ACCELERON PHARMA INC
Common Stock |
28 750 | ||||||||
2013-08-14 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −34 125 | 0 | −100,00 | |||
2013-08-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −34 125 | 433 916 | −7,29 | 33,26 | −1 135 141 | 14 433 869 |
2013-08-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 34 125 | 468 041 | 7,86 | 12,16 | 414 960 | 5 691 379 |
2013-08-05 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −49 625 | 0 | −100,00 | |||
2013-08-05 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 34 125 | −59,44 | |||
2013-08-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −10 700 | 433 916 | −2,41 | 35,41 | −378 867 | 15 364 141 |
2013-08-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −88 925 | 444 616 | −16,67 | 34,85 | −3 098 681 | 15 493 089 |
2013-08-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 49 625 | 533 541 | 10,25 | 14,57 | 723 036 | 7 773 692 |
2013-08-05 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 483 916 | 11,52 | 12,16 | 608 000 | 5 884 419 |
2013-07-09 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 84 125 | −37,28 | |||
2013-07-09 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 84 125 | −37,28 | |||
2013-07-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 433 916 | −10,33 | 28,19 | −1 409 735 | 12 234 131 |
2013-07-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 433 916 | −10,33 | 28,19 | −1 409 735 | 12 234 131 |
2013-07-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 483 916 | 11,52 | 12,16 | 608 000 | 5 884 419 |
2013-07-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 483 916 | 11,52 | 14,57 | 728 500 | 7 050 656 |
2013-07-02 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 134 125 | −27,16 | |||
2013-07-02 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 134 125 | −27,16 | |||
2013-07-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 433 916 | −10,33 | 29,84 | −1 492 050 | 12 948 487 |
2013-07-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 433 916 | −10,33 | 29,84 | −1 492 050 | 12 948 487 |
2013-07-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 483 916 | 11,52 | 12,16 | 608 000 | 5 884 419 |
2013-07-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 483 916 | 11,52 | 14,57 | 728 500 | 7 050 656 |
2013-06-07 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (right to buy) |
A - Award | 17 666 | 17 666 | |||||
2013-05-30 | 3 | EPZM |
Epizyme, Inc.
Common Stock |
60 000 | ||||||||
2013-05-29 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 55 000 | 55 000 | |||||
2013-05-29 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 300 000 | 300 000 | |||||
2013-05-23 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 15 000 | 15 000 | |||||
2013-05-22 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 24 375 | −25,00 | ||||
2013-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 835 | 433 916 | −0,88 | 31,98 | −122 643 | 13 876 634 | |
2013-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 437 751 | 1,89 | ||||
2013-05-21 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 16 250 | −33,33 | ||||
2013-05-21 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 835 | 429 626 | −0,88 | 31,04 | −119 038 | 13 335 591 | |
2013-05-21 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 433 461 | 1,91 | ||||
2013-05-21 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 8 125 | −50,00 | ||||
2013-05-21 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 836 | 425 336 | −0,89 | 31,69 | −121 563 | 13 478 898 | |
2013-05-21 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 429 172 | 1,93 | ||||
2013-04-01 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
M - Exercise | −12 000 | 0 | −100,00 | ||||
2013-04-01 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
F - Taxes | −10 469 | 1 531 | −87,24 | 12,15 | −127 198 | 18 602 | |
2013-04-01 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Common Stock |
M - Exercise | 12 000 | 12 000 | 10,60 | 127 200 | 127 200 | ||
2013-02-26 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −16 250 | 0 | −100,00 | |||
2013-02-26 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −16 250 | 421 047 | −3,72 | 20,72 | −336 654 | 8 722 915 |
2013-02-26 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 16 250 | 437 297 | 3,86 | 9,97 | 162 012 | 4 359 851 |
2013-02-20 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 16 250 | −75,47 | |||
2013-02-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 421 047 | −10,61 | 20,96 | −1 048 155 | 8 826 450 |
2013-02-20 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 471 047 | 11,88 | 9,97 | 498 500 | 4 696 339 |
2013-01-23 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 66 250 | −43,01 | |||
2013-01-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 421 047 | −10,61 | 22,30 | −1 114 775 | 9 387 453 |
2013-01-23 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 50 000 | 471 047 | 11,88 | 9,97 | 498 500 | 4 696 339 |
2013-01-15 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −39 970 | 116 250 | −25,59 | |||
2013-01-15 |
|
4 | ALKS |
Alkermes plc.
Incentive Stock Option (Right to Buy) |
M - Exercise | X | −10 030 | 0 | −100,00 | |||
2013-01-15 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −50 000 | 421 047 | −10,61 | 21,91 | −1 095 650 | 9 226 403 |
2013-01-15 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 39 970 | 471 047 | 9,27 | 9,97 | 398 501 | 4 696 339 |
2013-01-15 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 10 030 | 431 077 | 2,38 | 9,97 | 99 999 | 4 297 838 |
2012-11-19 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Award |
M - Exercise | −125 000 | 125 000 | −50,00 | ||||
2012-11-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −52 126 | 421 047 | −11,02 | 19,49 | −1 015 936 | 8 206 206 | |
2012-11-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 125 000 | 473 173 | 35,90 | ||||
2012-11-14 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −12 100 | 0 | −100,00 | |||
2012-11-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −12 100 | 348 173 | −3,36 | 20,25 | −244 966 | 7 048 797 |
2012-11-14 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 12 100 | 360 273 | 3,48 | 7,36 | 89 056 | 2 651 609 |
2012-10-19 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 900 | 12 100 | −19,33 | |||
2012-10-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −2 900 | 348 173 | −0,83 | 20,00 | −58 000 | 6 963 460 |
2012-10-19 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 2 900 | 351 073 | 0,83 | 7,36 | 21 344 | 2 583 897 |
2012-10-09 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −41 900 | 15 000 | −73,64 | |||
2012-10-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −41 900 | 348 173 | −10,74 | 20,31 | −850 939 | 7 070 976 |
2012-10-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 41 900 | 390 073 | 12,03 | 7,36 | 308 384 | 2 870 937 |
2012-10-09 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −58 100 | 56 900 | −50,52 | |||
2012-10-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −58 100 | 348 173 | −14,30 | 20,57 | −1 195 384 | 7 163 520 |
2012-10-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 58 100 | 406 273 | 16,69 | 7,36 | 427 616 | 2 990 169 |
2012-10-03 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 115 000 | −46,51 | |||
2012-10-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −100 000 | 348 173 | −22,31 | 20,52 | −2 051 660 | 7 143 326 |
2012-10-03 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 100 000 | 448 173 | 28,72 | 7,36 | 736 000 | 3 298 553 |
2012-09-26 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 215 000 | −31,75 | |||
2012-09-26 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −100 000 | 348 173 | −22,31 | 20,72 | −2 072 500 | 7 215 885 |
2012-09-26 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 100 000 | 448 173 | 28,72 | 7,36 | 736 000 | 3 298 553 |
2012-07-09 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −61 801 | 0 | −100,00 | |||
2012-07-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −61 801 | 348 173 | −15,07 | 17,52 | −1 082 871 | 6 100 652 |
2012-07-09 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 61 801 | 409 974 | 17,75 | 4,77 | 294 791 | 1 955 576 |
2012-07-06 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −7 900 | 61 801 | −11,33 | |||
2012-07-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −7 900 | 348 173 | −2,22 | 18,01 | −142 309 | 6 271 919 |
2012-07-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 7 900 | 356 073 | 2,27 | 4,77 | 37 683 | 1 698 468 |
2012-07-06 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −30 299 | 69 701 | −30,30 | |||
2012-07-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
S - Sale | X | −30 299 | 348 173 | −8,01 | 18,00 | −545 446 | 6 267 845 |
2012-07-06 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | X | 30 299 | 378 472 | 8,70 | 4,77 | 144 526 | 1 805 311 |
2012-05-29 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 981 | 348 173 | −0,57 | 16,14 | −31 973 | 5 619 512 | |
2012-05-24 |
|
4 | NBIX |
NEUROCRINE BIOSCIENCES INC
Stock Option |
A - Award | 15 000 | 15 000 | |||||
2012-05-22 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 32 500 | 32 500 | |||||
2012-05-22 |
|
4 | ALKS |
Alkermes plc.
Employee Stock Option (Right to Buy) |
A - Award | 450 000 | 450 000 | |||||
2012-05-21 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 24 375 | −25,00 | ||||
2012-05-21 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 389 | 350 154 | −0,96 | 16,42 | −55 647 | 5 749 529 | |
2012-05-21 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 353 543 | 2,35 | ||||
2012-05-18 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −8 125 | 16 250 | −33,33 | ||||
2012-05-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −3 389 | 345 418 | −0,97 | 16,71 | −56 630 | 5 771 935 | |
2012-05-18 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 125 | 348 807 | 2,38 | ||||
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Incentive Stock Option (Right to Buy) |
M - Exercise | X | −20 968 | 0 | −100,00 | |||
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −4 032 | 100 000 | −3,88 | |||
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
M - Exercise | X | −35 000 | 315 000 | −10,00 | |||
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Common Stock |
S - Sale | X | −20 968 | 340 682 | −5,80 | 18,83 | −394 895 | 6 416 132 |
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Common Stock |
M - Exercise | X | 20 968 | 361 650 | 6,15 | 4,77 | 100 017 | 1 725 070 |
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Common Stock |
S - Sale | X | −4 032 | 340 682 | −1,17 | 18,83 | −75 935 | 6 416 132 |
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Common Stock |
M - Exercise | X | 4 032 | 344 714 | 1,18 | 4,77 | 19 233 | 1 644 286 |
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Common Stock |
S - Sale | X | −35 000 | 340 682 | −9,32 | 18,83 | −659 162 | 6 416 132 |
2012-02-03 |
|
4 | ALKS |
Alkermes plc.
Common Stock |
M - Exercise | X | 35 000 | 375 682 | 10,27 | 7,36 | 257 600 | 2 765 020 |
2012-01-31 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Award |
M - Exercise | −25 000 | 0 | −100,00 | ||||
2012-01-31 |
|
4 | ALKS |
Alkermes plc.
Common Stock |
F - Taxes | −8 045 | 340 682 | −2,31 | 19,10 | −153 660 | 6 507 026 | |
2012-01-31 |
|
4 | ALKS |
Alkermes plc.
Common Stock |
M - Exercise | 25 000 | 348 727 | 7,72 |